InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in InMed Pharmaceuticals Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +11 vs. Q1 2026
- Shares held
- 2.70M
- +2.38M (+744.8%) vs. Q1 2026
- Total value
- $4.18M
- +$3.98M (+1,929.4%) vs. Q1 2026
- New holders
- 13
- 0 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $4.18M |
| Q1 2026 | 9 | $206.0K |
| Q4 2025 | 7 | $240.7K |
| Q3 2025 | 9 | $665.2K |
| Q2 2025 | 7 | $28.5K |
| Q1 2025 | 5 | $13.3K |
| Q4 2024 | 5 | $226.7K |
| Q3 2024 | 15 | $266.0K |
| Q2 2024 | 14 | $116.6K |
| Q1 2024 | 18 | $249.2K |
| Q4 2023 | 17 | $334.4K |
| Q3 2023 | 10 | $18.6K |
| Q2 2023 | 10 | $14.5K |
| Q1 2023 | 15 | $109.4K |
| Q4 2022 | 14 | $234.4K |
| Q3 2022 | 15 | $876.9K |
| Q2 2022 | 18 | $514.5K |
| Q1 2022 | 19 | $341.9K |
| Q4 2021 | 18 | $536.4K |
| Q3 2021 | 19 | $979.9K |
| Q2 2021 | 20 | $2.99M |
| Q1 2021 | 22 | $1.55M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding InMed Pharmaceuticals Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 800,000 | $1.24M | 0.06% | +800,000 | New |
| Vivo Capital, LLC | 798,377 | $1.24M | 0.11% | +798,377 | New |
| Squadron Capital Management LLC | 325,000 | $503.8K | 0.17% | +325,000 | New |
| Ikarian Capital, LLC | 245,025 | $379.8K | 0.06% | +245,025 | New |
| Ursa Fund Management, LLC | 125,800 | $195.0K | 0.03% | +125,800 | New |
| Suvretta Capital Management, LLC | 100,000 | $155.0K | 0.00% | +100,000 | New |
| Boothbay Fund Management, LLC | 74,244 | $115.1K | 0.00% | +74,244 | New |
| Sabby Management, LLC | 44,970 | $69.7K | 0.58% | −175,290−79.6% | Reduced |
| Jane Street Group, LLC | 43,078 | $66.8K | 0.00% | +43,078 | New |
| VR Adviser, LLC | 32,685 | $50.7K | 0.00% | +32,685 | New |
| Citadel Advisors LLC | 26,084 | $40.4K | 0.00% | −20,889−44.5% | Reduced |
| Seven Grand Managers, LLC | 25,000 | $38.8K | 0.00% | +25,000 | New |
| Scientech Research LLC | 15,461 | $24.0K | 0.02% | +15,461 | New |
| Crestwood Advisors Group LLC | 14,900 | $23.1K | 0.00% | +14,900 | New |
| Two Sigma Securities, LLC | 10,945 | $17.0K | 0.00% | −7,773−41.5% | Reduced |
| Stratos Wealth Partners, LTD. | 10,760 | $16.7K | 0.00% | +10,760 | New |
| Private Wealth Management Group, LLC | 5,000 | $7.75K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 300 | $465 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 2 | $4 | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 6 | – | – | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,980−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −8,068−100.0% | Sold out |